Major aesthetic medicine market players in Asia Pacific region include Allergan, Galderma, Shanghai Haohai Biological Technology Co., Ltd., Humedix, and Cynosure.

Pune, India, Sept. 15, 2022 (GLOBE NEWSWIRE) --

As per a recent industry report put forward by Graphical Research, the Asia Pacific aesthetic medicine market is forecast to register its name in the million-dollar fraternity down the line of seven years, by exceeding a revenue of USD 7.5 billion by 2027.

The market growth is due to increasing adoption of minimally invasive surgeries and advanced cosmetic procedures. Developments in both surgical and non-surgical aesthetic procedures will remain a catalyst amidst high costs and a lack of skilled manpower.

Access sample pages of the report, “Asia Pacific Aesthetic Medicine Market Forecasts 2027” in detail along with the table of contents (ToC) @

https://www.graphicalresearch.com/request/1795/sample

Some of the most popular aesthetic procedures, including lasers for hair removal, Botox, pigmentation reduction, skin resurfacing, and hyaluronic acid fillers are expected to be sought-after across the emerging economies. The number of aesthetic procedures declined during the onslaught of coronavirus, hampering the supply chain across the region.

Meanwhile, rising cases of obesity and the tendency to hide the signs of aging will continue to foster industry growth. According to a study, Asia Pacific aesthetic medicine market size would surpass USD 7.5 billion by 2027.

Surgical procedures to be sought-after

A dramatic rise in the number of facial aesthetic surgeries will encourage leading companies to expand their penetration across untapped areas. Besides, rampant breast cancer in Australia, China and India will usher the need for advanced procedures. Prominently, women have shown an increased preference for breast augmentation surgery. Asia Pacific aesthetic medicine market share from surgical procedures will observe a robust growth rate of around 7.9% up to 2027.

Significance of energy-based aesthetic medicine

Industry participants are expected to exhibit a preference for technologies, including cryolipolysis and radiofrequency for fat reduction, skin rejuvenation with minimal blood loss and invasion. Specifically, heightened awareness about light-based, laser-based and ultrasound aesthetic devices will bolster the growth potential. APAC industry value from energy-based aesthetic medicine could witness a healthy growth rate of more than 11.3% through 2027.

Females exhibit high preference for aesthetic medicine

A notable uptick in the number of breast augmentations, as well as the surge in the demand for facial aesthetic procedures, will augur well for the industry size expansion. Skin rejuvenation and injectables are likely to be preferred across the Pacific region. Female segment contributed around 75.4% share towards APAC aesthetic medicine market in 2020 and will witness an upward trend over 2021-2027.

Hospitals to invest in aesthetic medicine solutions

Hospitals are likely to count on the availability of advanced devices to boost the prospect of aesthetic medicine. Besides, investment in health infrastructure will further the penetration of skin rejuvenation, facial implants and ultrasound aesthetic devices. Hospitals accounted for around USD 1 billion in APAC aesthetic medicine industry in 2020 and will witness a robust outlook over the next few years.

Request for customization of this report @

https://www.graphicalresearch.com/request/1795/customize-this-report

Investments consistently rise in Japan

The surging geriatric population in Akita, Aomori, Fukushima and Yamanashi has made Japan a favorable market for aesthetic medicine. Citing the data from the National Institute of Population and Social Security Research, Nippon.com asserts the total number of seniors aged over 75 in Tokyo would rise to 2.27 million in 2045.

The tendency to minimize the signs of aging will set precedence in East Asia, thereby boosting the demand for the devices. Japan aesthetic medicine market was valued at over USD 500 million in 2020 and will witness an upward growth momentum by 2027.

While the dearth of care facilities and healthcare workers has been a major challenge, leading economies such as Japan and China are likely to underscore the industry growth. For instance, the presence of key players in China has made the mainland a happy hunting ground for developing advanced fillers. It is worth mentioning that the rising number of breast reconstruction procedures will also act as a major driver across APAC market.

North America Aesthetic Medicine Market Size By Product (Energy-based {Laser-based Aesthetic Device, Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device}, Non Energy-based {Botulinum Toxin, Dermal Fillers, Implants [Facial Implants, Breast Implants]}), By Type (Non-surgical, Surgical), By Gender (Male {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}, Female {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}), By End-use (Hospitals, Ambulatory Surgical Centres, Beauty Centres & Medical Spas, Dermatology Clinics, Home Settings), Research Report, Country Outlook (U.S., Canada), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027

https://www.graphicalresearch.com/industry-insights/1798/north-america-aesthetic-medicine-market

Europe Aesthetic Medicine Market Size By Gender (Male {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}, Female {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}), By Type (Non-surgical, Surgical), By Product (Energy-based {Laser-based Aesthetic Device, Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device}, Non Energy-based {Botulinum Toxin, Dermal Fillers, Implants [Facial Implants, Breast Implants]}), By End-use (Hospitals, Ambulatory Surgical Centres, Beauty Centres & Medical Spas, Dermatology Clinics, Home Settings), Research Report, Country Outlook (Germany, UK, France, Italy, Spain, Russia, Poland, Turkey, Belgium, Greece), Price Trends, Growth Prospects, COVID-19 Impact Statistics, Competitive Industry Share & Forecasts, 2021 – 2027

https://www.graphicalresearch.com/industry-insights/1812/europe-aesthetic-medicine-market

‘Graphical Research’ provides a large collection of market research and industry analysis reports covering healthcare, automotive, oil and gas, pharmaceutical, IT, agriculture, chemicals, and many other sectors, across diverse regions like North America, Europe, Asia Pacific, Latin America, and others. The comprehensive reports we provide are aligned with the key industry trends and insights in specific regional markets. The data we deliver helps our customers make better strategic decisions. Our goal is to offer competitive and quality customized market research reports.

AT&T CEO John Stankey has a message to rival T-Mobile: Cut the nonsense when advertising to seniors.

Now-redundant, Ethereum miners are flocking to other proof-of-work (PoW) tokens after the network switched to the proof-of-stake (PoS) consensus mechanism.

As bad the news was for FedEx, it may be worse news for the U.S. economy --- and an early sign of a recession.

FedEx has blown three tires before the peak holiday shipping season, and chatter on the Street is that mighty Amazon may have played a role.

'He has gotten nowhere,' said West's lawyer about his attempts to work through partnership issues

These highly profitable companies offer sustainable competitive advantages that make them no-brainer buys.

NCR Corp. (NYSE: NCR) shareholders lost ground to a falling market on Friday. NCR announced late on Thursday that it is separating into an ATM business and a digital commerce business, rather than controlling the two under one enterprise. "NCR has the opportunity to unlock value for our shareholders by separating our digital commerce business and our ATM business," executive chairman Frank Martire said in a press release.

Recent developments suggest business trends are getting worse---not better, meaning there could be more downside ahead.

(Bloomberg) -- Wall Street analysts didn’t mince words in discussing FedEx Corp.’s forecast for the current quarter -- which missed by a landslide -- and its withdrawal of full-year guidance. It’s really bad.Most Read from BloombergGermany Tightens Control Over Industry With Russian Oil GrabJeff Bezos Loses Spot as World’s Second Richest Person to Gautam AdaniPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitAdobe Near Deal for Online Design Startup Figma, Sources SayPutin Ack

Nile Global CEO Pankaj Patel talks about why he and former Cisco colleague John Chambers think they have what networking customers want today.

Indian billionaire Gautam Adani is now the world’s second richest person. The only person richer than him now is Tesla chief Elon Musk.

More Americans are working into their golden years. Here's how Medicare, Social Security, taxes and other factors come into play.

(Bloomberg) -- FedEx Corp. saw its biggest stock drop since at least 1980 after withdrawing its earnings forecast on worsening business conditions, a potentially worrying sign for the global economy.Most Read from BloombergGermany Tightens Control Over Industry With Russian Oil GrabJeff Bezos Loses Spot as World’s Second Richest Person to Gautam AdaniPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitAdobe Near Deal for Online Design Startup Figma, Sources SayPutin Acknowledges

While more and more automakers are adopting lidar technology for safer driving, a clear leader in the space has yet to emerge. Lidar, which stands for "light detection and ranging," uses lasers to allow cars to "see" other vehicles and potential obstacles in their path. Luminar Technologies (NASDAQ: LAZR) has always been the lidar darling -- largely for being one of the first to go public, and early to win high-profile production contracts with Volvo for hands-free, eyes-off highway driving, and from Polestar.

A Virginia state court confirmed the eye-popping $2 billion verdict against Pegasystems Inc., which the Cambridge-based software maker plans to appeal in a court battle with rival Appian that could potentially last years.

Microsoft Corp. (Nasdaq: MSFT) and Zillow Group Inc. (Nasdaq: ZG) are being accused of wiretapping, according to a class action lawsuit filed Monday by two visitors to Zillow's website. The complaint, filed in the U.S. District Court for Western Washington, alleges that Zillow, a Seattle-based online real estate platform, used a third-party tool from Redmond-based software maker Microsoft to track detailed behaviors of website visitors. While sites and platforms like Facebook and Google use users' location and browsing data to track activity, the suit says that because neither Zillow nor Microsoft received consent to do so, it was illegal.

Though the mining industry has been hit hard in recent years, this gold producer is going strong and continues to grow

Warren Buffett is one of the best investors of all time. Since 1965, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B), the masterfully crafted conglomerate he helped build, has returned over 20% annually, creating fortunes for its shareowners along the way. Berkshire's public stock portfolio is thus closely watched by investors seeking to build lasting wealth in the stock market.

A U.S. International Trade Commission judge has sided with DISH Network in a case alleging that Peloton, iFit, and Lululemon’s Mirror infringed on patents.

From couture fashion, to high-end automobiles, it seems luxury buyers can’t get enough. Here's how you can invest in the luxury goods boom.